Evidence map›Paper›PMID 35321258›Full record

ArticleJAAD case reports2022

Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil.

Anna Lyakhovitsky, Oz Segal, Alexander Maly, Abraham Zlotogorski, Aviv Barzilai

Abstract readCase Reports
In one paragraph

Article in JAAD case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Cancer-Related Alopecia Risk and Treatment.Current treatment options in oncology · 2025
    Review
  3. Oral minoxidil for late alopecia in cancer survivors.Breast cancer research and treatment · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Hair loss during and after breast cancer therapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Review
  9. Chemotherapy: how to reduce its adverse effects while maintaining the potency?Medical oncology (Northwood, London, England) · 2023
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna LyakhovitskyDepartment of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
Oz SegalDepartment of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
Alexander MalyDepartment of Pathology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
Abraham ZlotogorskiDepartment of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
Aviv BarzilaiDepartment of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AGA, androgenetic alopeciaGVHD, graft-versus-host diseasehair follicleLDOM, low-dose oral minoxidillow-dose oral minoxidilnoncicatricial alopeciapCIA, permanent chemotherapy-induced alopeciapermanent chemotherapy-induced alopeciaTMS, topical minoxidil solutiontreatment

Identifiers

PMID35321258
PMCPMC8935347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.